Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Key Highlights
- ➤Elutia granted 378,000 inducement stock options to two new employees
- ➤Options exercise price was $0.93 per share
- ➤Options vest 25% after one year, then monthly over three years
GAITHERSBURG, Md., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a drug delivery company built to stop surgical infections, today announced that it granted equity awards on November 10, 2026 to two new employees as inducement awards under the Elutia Inc. 2026 Inducement Award Plan (the “Plan”). The awards were approved by the independent Compensation Committee of the Board of Directors and were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
Under the Plan, the two new employees received an aggregate of 378,000 non-qualified stock options (the “Options”). The Options vest 25% on the first anniversary of their vesting commencement dates, with the balance vesting in equal monthly installments over the following three years. Vesting is subject to each recipient’s continued employment through the applicable vesting date. The Options had an exercise price of $0.93 per share, the closing price of Elutia’s common stock on the Nasdaq Capital Market on November 10, 2026, the grant date. The Options are subject to the terms and conditions of the Plan and the applicable stock option agreement.
Get started
Create a free account to read the full story.
